Drug
Mesutoclax
Mesutoclax: highest development phase Phase 3, developed by Beijing InnoCare Pharma Tech Co., Ltd.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Beijing InnoCare Pharma Tech Co., Ltd.
Trials
| Drug | Phase | Indication |
|---|---|---|
| Mesutoclax (ICP-248) NCT07925190 | Phase 3 | Acute Myeloblastic Leukemia |
Latest
No recent events.
Follow Mesutoclax on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.